Skip to content
Screener

Sana Biotechnology SANA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$128.67M-8.3%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
6.5%+0.2pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$347.66M-7.5%
Prime Medicine logo
Prime MedicinePRME
$120.47M+0.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$85.95M-33.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$20M+21.1%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$1B+35.5%
Enterprise value$996.16M+31.8%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216769
Line itemMarch 31, 2026December 31, 2025
Prepaid expenses and other current assets6,3596,099
Total current assets111,690148,676
Property and equipment, net25,67326,906
Operating lease right-of-use assets35,84538,313
Intangible asset59,19559,195
Goodwill140,627140,627
Other non-current assets5633,173
TOTAL ASSETS$373,593$416,890

Item 1. Financial Statements

FAQ

What is Sana Biotechnology's operating lease ROU assets?
Sana Biotechnology (SANA) reported operating lease ROU assets of $35.85M in Q1 2026.
How has Sana Biotechnology's operating lease ROU assets changed year-over-year?
Sana Biotechnology's operating lease ROU assets decreased by 34.6% year-over-year, from $54.84M to $35.85M.
What is the long-term trend for Sana Biotechnology's operating lease ROU assets?
Over 5 years (2020 to 2025), Sana Biotechnology's operating lease ROU assets has grown at a -9.5% compound annual growth rate (CAGR), from $63.17M to $38.31M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Sana Biotechnology's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude